Perrigo Company PLC (PRGO.N)
21 Feb 2018
* PERRIGO CONFIRMS PATENT CHALLENGE FOR GENERIC VERSION OF FINACEA® FOAM, 15%
* PERRIGO APPOINTS RONALD L. WINOWIECKI AS CHIEF FINANCIAL OFFICER
* PERRIGO ANNOUNCES TENTATIVE FDA APPROVAL FOR THE GENERIC VERSION OF SOOLANTRA® CREAM, 1% Source text for Eikon: Further company coverage:
* PERRIGO ANNOUNCES FINAL FDA APPROVAL OF A GENERIC VERSION OF ESTRACE CREAM
* PERRIGO ANNOUNCES FINAL FDA APPROVAL AND LAUNCH OF AN AB RATED GENERIC VERSION OF EPIDUO GEL Source text for Eikon: Further company coverage:
BRIEF-Perrigo Says In Connection With Uwe Röhrhoff's Appointment As CEO, Co's Unit Perrigo DAC Entered Into Employment Agreement With Him
* PERRIGO COMPANY - IN CONNECTION WITH UWE RÖHRHOFF'S APPOINTMENT AS CEO, CO'S UNIT PERRIGO DAC ENTERED INTO AN EMPLOYMENT AGREEMENT WITH HIM
Generic drugmaker Perrigo Company Plc appointed Uwe Rohrhoff, former CEO of Gerresheimer AG, as its new chief executive, the company said on Monday.
Jan 8 Generic drugmaker Perrigo Company Plc appointed Uwe Rohrhoff, former CEO of Gerresheimer AG , as its new chief executive, the company said on Monday.
Jan 8 Generic drugmaker Perrigo Company Plc appointed former Gerresheimer AG Chief Executive Uwe Rohrhoff as its new president and CEO, the company said on Monday.
* PERRIGO APPOINTS UWE RÖHRHOFF AS PRESIDENT & CHIEF EXECUTIVE OFFICER
|Dr.Reddy's Laboratories Ltd (REDY.NS)||Rs2,165.90||--|
|Abbott Laboratories (ABT.N)||$58.99||-0.13|
|Mead Johnson Nutrition CO (MJN.N)||--||--|
|Nestle SA (NESN.S)||CHF75.04||-0.16|
|Danone SA (DANO.PA)||€64.71||--|
|Bayer AG (BAYGn.DE)||€98.43||-0.50|
|Bayer AG (BAYE.F)||--||--|
|Pfizer Inc. (PFE.N)||$35.76||-0.25|
|Impax Laboratories Inc (IPXL.OQ)||$20.40||+0.70|
|Taro Pharmaceutical Industries Ltd. (TARO.N)||$100.69||+0.56|